Skip to main content

Table 1 Distribution of the responses to the case vignette

From: International variation in the management of severe COVID-19 patients

Numbers (%) or median (interquartile ranges) Total, 1001 respondents
1. Admission to the ICU of a previously healthy 39-year-old man with severe COVID-19
 Direct admission to the ICU 55%
 Admission in an intermediate care unit 34.2%
 Delayed admission to the ICU because of lack of bed 1.3%
 Patient stays in the emergency department 0.8%
 Patient admitted in the wards 8.8%
2. Initial oxygenation strategy
 I increase the oxygen flow to 15 l/min keeping the face mask 24.2%
 I change the mask for a Venturi mask 17.5%
 I start CPAP or noninvasive ventilation 25.5%
 I start high flow nasal oxygen 47.1%
 I intubate the patient right away 7.4%
 I add prone positioning on spontaneous breathing 37.9%
3. Optimizing oxygenation in a patient with a PF ratio of 84 4 h after intubation
 I will give neuromuscular blockade for 24–48 h 50.9%
 I increase and titrate PEEP to optimize recruitment 61.4%
 I prone the patient immediately 73.2%
 I am considering ECMO immediately 4.7%
 Let us wait a little bit 9.9%
4. Regarding the initial antibiotics
 All my patients receive a broad anti-bacterial agent 45.3%
 I only give broad anti-bacterial agent to febrile patients 11%
 I only give broad anti-bacterial agent if CRP or PCT are high 4.2%
 I only give broad anti-bacterials to patients with structural lung diseases 35.8%
 I never give broad anti-bacterial agent in severe viral infections 3.7%
5. Regarding initial anti-viral therapy, several options are possible
 The level of evidence is so low that there is nothing I can give 48.9%
 I prescribe (hydroxy)chloroquine 42.7%
 I prescribe lopinavir/ritonavir 17.0%
 I prescribe remdesivir 15%
 I prescribe another anti-viral drug 4.6%
6. Are you starting an anti-inflammatory therapy?  
 No 52.4%
 Yes IL-1 or IL-6 blockade 24.8%
 Yes, complement blockade 1.4%
 Yes, steroids 31.5%
 Yes, another anti-inflammatory drug 2.4%